Acuitas Investments Updates InfuSystem Holdings Stake
Ticker: INFU · Form: SC 13G/A · Filed: Feb 2, 2024 · CIK: 1337013
| Field | Detail |
|---|---|
| Company | Infusystem Holdings, INC (INFU) |
| Form Type | SC 13G/A |
| Filed Date | Feb 2, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investment
TL;DR
**Acuitas Investments still holds InfuSystem stock, signaling continued institutional interest.**
AI Summary
Acuitas Investments, LLC, a Seattle-based investment firm, filed an amended Schedule 13G/A on February 2, 2024, indicating its ownership of InfuSystem Holdings, Inc. common stock as of December 31, 2023. This filing updates their previous disclosure, confirming their continued passive investment in the medical instruments company. This matters to investors because it shows a significant institutional investor maintains a position, which can signal confidence in the company's long-term prospects.
Why It Matters
This filing confirms Acuitas Investments' ongoing passive stake in InfuSystem Holdings, providing transparency into institutional ownership and potentially influencing investor sentiment.
Risk Assessment
Risk Level: low — This is a routine amendment to a passive ownership filing and does not indicate any immediate risk or significant change in strategy.
Analyst Insight
A smart investor would note Acuitas Investments' continued passive stake in InfuSystem Holdings, but recognize this filing is routine and doesn't signal an immediate buy or sell action. It's a data point for long-term sentiment.
Key Players & Entities
- Acuitas Investments, LLC (company) — the entity filing the SC 13G/A
- InfuSystem Holdings, Inc. (company) — the subject company whose stock is being reported
- Lisa Thenell (person) — Chief Compliance Officer for Acuitas Investments, LLC
- Seattle, WA (location) — business address for Acuitas Investments, LLC
- December 31, 2023 (date) — date of the event requiring the filing
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing under the Securities Exchange Act of 1934, as indicated by 'FORM TYPE: SC 13G/A' and 'SCHEDULE 13G (Amendment No. 1)*'.
Who is the reporting person in this filing?
The reporting person is Acuitas Investments, LLC, as stated under 'FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Acuitas Investments, LLC'.
What is the subject company of this filing?
The subject company is InfuSystem Holdings, Inc., as identified under 'SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: InfuSystem Holdings, Inc'.
What is the CUSIP number for the class of securities reported?
The CUSIP number for the Common Stock, $0.0001 Par Value of InfuSystem Holdings, Inc. is 45685K102, as listed in the filing.
When was the event that required this filing?
The date of the event which required the filing of this statement was December 31, 2023, as explicitly stated in the document.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on February 2, 2024 by Lisa Thenell regarding InfuSystem Holdings, Inc (INFU).